Abstract-Aldosterone (Aldo) is involved in vascular remodeling and inflammation; however, the mechanisms are imperfectly defined. We hypothesized that Aldo alters endothelial integrity and modifies paracellular permeability. Human umbilical vein endothelial cells were exposed to Aldo (10 -9 mol/L) and alterations in paracellular permeability, assembly of tight and adherens junctions and activation of intracellular signaling pathways were determined. Aldo increased endothelial permeability for molecules ≤70 kDa within 60 minutes. A transient loss of cortical actin with formation of actin stress fibers and disruption of continuous adherens and tight junction strands accompanied these changes. Mineralocorticoid receptor blockade, inhibition of RhoA, or disruption of extracellular-regulated protein kinase1/2 signaling pathways attenuated the Aldo-related effects. Moreover, Aldo-induced cytoskeletal rearrangement led to rapid dephosphorylation of protein kinase B and subsequent deactivation of endothelial nitric oxide synthase. Ex vivo tracer flux experiments with Evans blue-conjugated albumin demonstrated a concordant response to Aldo in freshly isolated umbilical arteries. Furthermore, low-dose cortisol (3×10 -10 to 3×10 -9 mol/L) mimics the effect of Aldo on endothelial integrity, and Aldo, by upregulating11β-hydroxysteroid dehydrogenase type 2, might even aggravate this deleterious effect of low-dose cortisol. We suggest that these mechanisms may contribute to the vasculopathy induced by inappropriate mineralocorticoid receptor activation. 
ndothelial cells form a thin monolayer lining the inner surface of blood and lymphatic vessels. The cells are connected by intercellular junctions, which control a variety of cellular properties, including adhesion, cell migration, paracellular transport, and leukocyte infiltration. In contrast to epithelial cells with their highly conserved junction structures, endothelial cells showed a higher variability with formation of adherens, tight and gap junctions along the entire cell-cell contact area. 1 Moreover, the composition of endothelial tight and adherens junctions differs from that of epithelial cells. Thus, endothelial adherens junctions are mainly composed of vascular endothelial cadherin (VE-cadherin) and catenins linking the junctions to the actin cytoskeleton.
The main constituents of endothelial tight junctions are occludin, claudin-5, and the junctional adhesion molecules. These membrane-spanning proteins are anchored to the cytoskeleton via adaptor proteins, including zonula occludens (ZO) proteins, afadin, or cingulin. However, the cytoskeleton of the cell not only serves as an attachment point but also actively controls maintenance and assembly of tight and adherens junctions. In a variety of pathophysiological conditions, disassembly of endothelial tight junctions has been described, for example, ischemia-induced cerebral edema formation, viral or bacterial penetration, and cerebral edema attributed to malignant brain tumors. [2] [3] [4] [5] Several molecules are known to modulate the integrity of tight junctions. Although vascular endothelial growth factor, histamine, thrombin, or reactive oxygen species promote breakdown of endothelial tight junctions, transforming growth factor-β or synthetic steroids, such as dexamethasone (DM), protect junction architecture. [6] [7] [8] [9] Aldosterone (Aldo) regulates volume homeostasis in the kidney. In addition, Aldo has been shown to modify many pathophysiological processes, including inflammation, fibrosis, immune responses, and vascular integrity. 10 Although hyperaldosteronism impairs vascular function and endothelial remodeling, 11 mineralocorticoid receptor (MR) antagonists like spironolactone or eplerenone (EPL) show beneficial influences on vascular integrity and reduced cardiovascular mortality. 12, 13 The aim of the current study was to characterize the effect of Aldo on cytoskeletal rearrangement processes and on barrier properties in human endothelial cells.
We measured Aldo-induced alterations in vascular permeability toward Evans blue-conjugated albumin in human umbilical arteries. Preliminary experiments revealed that Aldo exerts its most prominent effect on paracellular permeability after 60 minutes at concentrations of 10 -9 to 10 -10 mol/L ( Figure  S1 , available in the online-only Data Supplement). Therefore, the following experiments were performed with an Aldo concentration of 10 -9 mol/L. After 60 minutes, albumin flux significantly increased compared with Ringer solution alone (242±108 µg of BSA/mg of dry tissue versus 120±63 µg of BSA/mg of dry tissue; P<0.001). Elevated albumin extravasation could be prevented by pretreating the arteries with EPL for 30 minutes (111±51 µg of BSA/mg of dry tissue; P<0.001; Figure 1A ).
We then determined the effects of Aldo on paracellular permeability in cAMP-treated human umbilical vein endothelial cells (HUVECs). 14 To test, whether the density of endothelial monolayer influenced expression of the MR, transcript amounts were analyzed by real-time quantitative PCR. MR mRNA level decreased with increasing density of the HUVEC monolayer, and stimulation with cAMP even further reduced the amount of MR transcript ( Figure 1B) . However, intracellular cAMP levels were not regulated by Aldo itself (10 -6 to 10 -11 mol/L; data not shown). Tracer flux assays revealed that Aldo induced a clear, time-dependent transient increase in paracellular permeability toward both 10 and 70 kDa dextrans with a peak observed after 60 minutes (7.9±1.6-fold increase for the 10 kDa dextran and 1.8±0.3-fold increase for the 70 kDa dextran; P<0.01; Figure 1C ). In HUVECs that were not treated with cAMP, Aldo induced a much lower but still significant increase in permeability toward the 10-kDa dextran, whereas paracellular flux of the 70-kDa dextran did not change at any time point ( Figure 1D ).
Aldo Induces Remodeling of the Actin Cytoskeleton and Alters Assembly of Adherens and Tight Junctions
Next, we analyzed Aldo-dependent changes in actin distribution in HUVECs. In concordance with the tracer flux assays, remodeling of the actin cytoskeleton occurred as fast as 30 minutes after the addition of Aldo. Cortical F-actin bands dissolved and the cells started forming actin stress fibers. After 60 minutes, the cortical F-actin ring completely disappeared, and actin stress fibers were clearly visible. Within the next 3 hours, cortical F-actin bands were reconstituted. Consistent with the changes in F-actin distribution, Aldo induced a transient redistribution of the adherens junction protein VE-cadherin, as well as formation of intercellular gaps. The same pattern could be seen for the tight junction adaptor protein ZO-1 and the transmembrane proteins claudin-5 and occludin ( Figure  2A ). Longer incubation periods ≤24 hours had no significant impact on both actin cytoskeleton reorganization and distribution of junction-associated proteins (data not shown). In HUVECs cultivated without cAMP, rearrangement of cortical actin structures and reassembly of continuous junction strands were less prominent after 4 hours, suggesting that exposure to external cAMP did not alter the effect of Aldo on cell contraction and junction disassembly but induced a much faster resealing of intercellular contacts in endothelial cells ( Figure  2B ). Moreover, re-exposure to Aldo for 60 minutes showed comparable effects on junction disassembly compared with a single exposure, demonstrating that the response to Aldo is not sensitive to tachyphylaxis ( Figure 2C ). Stimulation with Aldo for ≤4 hours had no significant effect on mRNA expression of VE-cadherin and occludin but induced a slight increase in claudin-5 and ZO-1 expression ( Figure 2D ).
Inhibition of the MR Restored Junctional Integrity
To elucidate involvement of the MR in Aldo-induced alterations of the cytoskeleton and junction architecture, HUVECs were pretreated with the MR inhibitor EPL (10 -5 mol/L) before exposure to Aldo. EPL partially prevented the formation of F-actin stress fibers compared with cells that were vehicle treated. Aldo-induced disruption of continuous junction strands could also be attenuated by EPL ( Figure 3A) . Moreover, pretreatment with EPL significantly reduced permeability in Aldo-treated cells ( Figure 3B ).
Effect of Aldo Is Mediated by ExtracellularRegulated Protein Kinase1/2 and RhoA
Exposure to Aldo induced a significant phosphorylation of the extracellular signal-regulated kinase (ERK) 1/2. Concordantly, blocking ERK1/2 phosphorylation successfully prevented disassembly of cortical actin rings and continuous junction strands in response to Aldo ( Figure 4A ). Because formation of actin stress fibers suggests involvement of the RhoA/ROCK pathway, we performed RhoA activation assays. Aldo induced a very rapid activation of RhoA within the first minutes, and inhibition of the RhoA/ROCK pathway prevented formation of actin stress fibers in response to Aldo ( Figure 4B ).
Aldo Regulates Activity of Protein Kinase B and Endothelial NO Synthase
Next, we analyzed the time course of protein kinase B (AKT) and endothelial nitric oxide (NO) synthase (eNOS) phosphorylation in response to Aldo. Phosphorylation of AKT and of eNOS at Ser1177 increased enzyme activity, whereas phosphorylation of eNOS at position Tyr657 attenuated eNOS activation and NO generation. AKT was dephosphorylated 5 to 10 minutes after cells were exposed to Aldo and returned toward baseline after 30 to 45 minutes. The same temporal pattern could be observed for phosphorylation of eNOS at Tyr657, whereas dephosphorylation of eNOS at Ser1177 showed a peak after 15 minutes ( Figure 5A ). Concordantly, nitrate/nitrite level decreased 10 to 15 minutes after addition of Aldo, whereas pretreatment with EPL partly prevented the decline in NO production ( Figure 5B ). Dephosphorylation of AKT and (Ser1177) eNOS, as well as decreased NO production in response to Aldo, could be circumvented by inhibition of the RhoA/ROCK pathway ( Figure 5C ), whereas constitutively active AKT prevented neither Aldo-induced permeability nor cytoskeletal or cell junction rearrangement (data not shown).
Cortisol Partly Mimics the Effect of Aldo on Endothelial Integrity
Because the MR is also targeted by glucocorticoids, we asked whether cortisol could mimic or counteract the effect of Aldo in endothelial cells. We, therefore, measured paracellular permeability toward 70 kDa dextran in response to increasing concentrations of cortisol. As shown in Figure 6A , low levels (3×10 -10 to 3×10 -9 mol/L) of cortisol significantly increased paracellular permeability and influenced distribution of junction-associated proteins as shown by immunostaining for ZO-1. Cortisol is converted to the inactive cortisone by the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2). Exposure to Aldo induced a significant increase in endothelial 11βHSD2 both on transcript and on protein level ( Figure 6B ), which possibly aggravates the deleterious effect of cortisol on endothelial function. On the other side, exposure to cortisol led to an only moderate increase in ERK activation ( Figure S2 ). Also, nitrate/nitrite release was not influenced by cortisol (data not shown).
Discussion
Primary and secondary hyperaldosteronism are receiving increasing attention because Aldo affects multiple cellular responses and modulates vascular and tissue remodeling cascades. 15 Here, we demonstrated that Aldo temporarily increases vascular permeability and modulates rearrangement of the actin cytoskeleton and tight and adherens junctions. These responses were accompanied by a RhoA/ROCKdependent decrease of AKT and eNOS activity. Cell-cell junctions control a variety of crucial processes, such as cell adhesion, polarity, permeability, or leukocyte transmigration, and disassembly of cell-cell junctions is linked to several pathological conditions. [16] [17] [18] [19] Two major groups of hormones of the adrenal gland belong to the physiological mediators that alter junctional architecture, glucocorticoids and mineralocorticoids. Glucocorticoids like cortisol or the synthetic derivates DM and triamcinolone acetonide have been shown to induce formation of tight junctions in both epithelial and endothelial cells in vitro. [20] [21] [22] Moreover, because of their junction-stabilizing effects, glucocorticoids successfully counteract breakdown of tight junction structures under inflammatory conditions like oxidative stress or enhanced tumor necrosis factor-α exposure. 23, 24 However, most of those studies analyzed endothelial junctions or barrier function in response to DM or triamcinolone acetonide, but, in contrast to cortisol, these synthetic glucocorticoids have only minor, if any, effect on the MR. In this study, we could demonstrate that exposure to low-dose cortisol mimics the effect of Aldo on the endothelium rather than counteracting it. This finding might be explained by the affinity of cortisol to the MR at physiological levels. Moreover, most of the studies analyzing glucocorticoids chose longer exposure periods (>24 hours), and rather few data exist on short-term effects of cortisol on endothelial barrier properties. In this regard, it is noteworthy that Aldo induced the expression of 11βHSD2 in a very rapid and thus nongenomic way, leading to an even lower cortisol level. Hence, our results strengthen the hypothesis that MR activation reflects not necessarily Aldo-mediated effects but also those of glucocorticoids. 25 Aldo, the most important mineralocorticoid, has mainly been studied for its influence on tight junctions in the kidney. In renal collecting duct cells, Le Moellic et al 26 found that Aldo (10 -9 mol/L) rapidly changed permeability by modulating phosphorylation of claudin-4. Other investigators demonstrated that, in the colon, Aldo mediates alterations in Na + absorption, paracellular permeability, and resistance. 27 In vascular cells, Aldo leads to RhoA-dependent formation of actin stress fibers, cytoskeletal remodeling, and cell migration. 10, 28, 29 Others 30, 31 showed that Aldo induces augmented release of Weibel-Palade bodies and triggers enhanced adhesion of leukocytes. Both effects may be explained by the modifying effect of Aldo on tight junctions as delineated in this study.
Moreover, disorganized cell-cell junctions are considered to be a prerequisite for tumor-induced angiogenesis, 32 and the recent findings that Aldo is capable of modulating expression of proteins associated with angiogenesis, neovascularization, or vascular leakage are of particular interest and support the hypothesis of Aldo being a promoter of vascular rearrangement and (neo-)angiogenesis. [33] [34] [35] In this study, we observed not only cytoskeletal and tight junction rearrangement processes in response to Aldo but also changes in the distribution pattern of VE-cadherin. VE-cadherincontaining adherens junctions have been described to actively control proper tight junction formation, and the question as to what extent Aldo-induced VE-cadherin redistribution actively influences the composition and integrity of tight junctions remains to be determined. 36 On the other hand, Aldo-induced actin stress fiber formation and subsequent cell contraction might be the initial cause for altered junction distribution.
Our findings, that RhoA and ERK1/2 inhibition prevented cytoskeletal and junction rearrangement, demonstrate that, at least in part, Aldo modulates actin rearrangement and endothelial barrier function via the RhoA/ROCK pathway. Moreover, our results regarding enhanced expression of junction proteins in response to Aldo are in line with other studies showing that Aldo, via genomic and nongenomic mechanisms, modulates expression of several genes in endothelial cells. 31, [37] [38] [39] Notably, there was a strong temporal correlation among junction rearrangement, enhanced permeability, and deactivation of AKT and eNOS. Basile et al 40 have demonstrated that plexin-B1-induced activation of RhoA/ROCK leads to enhanced activation of Pyk2, which, in turn, activates phosphatidylinositol 3-kinase, AKT, and ERK. In addition to activation of the phosphatidylinositol 3-kinase/AKT pathway, Pyk2 is known to be responsible for phosphorylation of eNOS at Tyr657, which leads to attenuation of enzyme activity. Others have shown that increased RhoA activity modulates phosphorylation of both the mitogen-activated protein kinase and the phosphatidylinositol 3-kinase/AKT pathway. 41, 42 A recently published study showed that Aldo decreases endothelial NO levels and modulates pulmonary arterial hypertension. 43 Our results, in combination with these findings, suggest a model in which mineralocorticoids like Aldo modulate endothelial integrity by MR-dependent redistribution of cytoskeletal and junction structures, enhanced paracellular permeability, and altered eNOS activity.
Perspectives
We have shown that Aldo is capable of inducing rearrangement processes of the endothelial actin cytoskeleton leading to alterations of cell-cell junctions, barrier properties, and NO production. We also introduced the first data on low-dose cortisol effects on endothelial integrity. These findings pave the way for further studies on corticoid-mediated vascular alterations in vitro, as well as in experimental animal models addressing target-organ damage. 
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